Destination Maternity (DESTQ) 10-Q 11 Dec 18 2018 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Nov. 03, 2018	Nov. 30, 2018
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Nov. 3, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q3
Trading Symbol	DEST
Entity Registrant Name	Destination Maternity Corp
Entity Central Index Key	896,985
Current Fiscal Year End Date	--02-02
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		14,447,524

CONSOLIDATED BALANCE SHEETS (un

CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018
Current assets:
Cash and cash equivalents	$ 1,247	$ 1,635
Trade receivables, net	7,261	6,692
Inventories	79,054	71,256
Prepaid expenses and other current assets	10,270	11,522
Total current assets	97,832	91,105
Property and equipment, net of accumulated depreciation and amortization of $106,276 and $98,024	55,158	66,146
Other assets:
Deferred line of credit financing costs, net of accumulated amortization of $898 and $829	383	450
Other intangible assets, net of accumulated amortization of $1,027 and $907	863	953
Deferred income taxes	4,805	2,829
Other non-current assets	1,064	1,099
Total other assets	7,115	5,331
Total assets	160,105	162,582
Current liabilities:
Line of credit borrowings	21,700	8,000
Current portion of long-term debt	4,729	4,780
Accounts payable	25,767	30,949
Accrued expenses and other current liabilities	30,988	31,661
Total current liabilities	83,184	75,390
Long-term debt	22,704	23,809
Deferred rent and other non-current liabilities	20,856	22,715
Total liabilities	126,744	121,914
Commitments and contingencies (Note 15)
Stockholders’ equity:
Preferred stock, 1,656,381 shares authorized, none outstanding
Common stock, $.01 par value; 20,000,000 shares authorized, 14,447,524 and 14,684,117 shares issued and outstanding	145	147
Additional paid-in capital	107,482	106,865
Accumulated deficit	(74,192)	(66,274)
Accumulated other comprehensive loss	(74)	(70)
Total stockholders’ equity	33,361	40,668
Total liabilities and stockholders’ equity	$ 160,105	$ 162,582

CONSOLIDATED BALANCE SHEETS (_2

CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018
Statement Of Financial Position [Abstract]
Property and equipment, accumulated depreciation and amortization	$ 106,276	$ 98,024
Deferred line of credit financing costs, accumulated amortization	898	829
Other intangible assets, accumulated amortization	$ 1,027	$ 907
Preferred stock, shares authorized	1,656,381	1,656,381
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	14,447,524	14,684,117
Common stock, shares outstanding	14,447,524	14,684,117

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Income Statement [Abstract]
Net sales	$ 92,837	$ 96,354	$ 292,459	$ 301,060
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of goods sold	$ 44,181	$ 45,453	$ 138,535	$ 140,167
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Gross profit	$ 48,656	$ 50,901	$ 153,924	$ 160,893
Selling, general and administrative expenses	48,629	53,234	150,581	161,689
Store closing, asset impairment and asset disposal expenses	1,028	1,011	2,669	3,649
Other charges, net	1,825	3,100	4,898	3,746
Operating loss	(2,826)	(6,444)	(4,224)	(8,191)
Interest expense, net	1,232	1,006	3,533	2,989
Loss before income taxes	(4,058)	(7,450)	(7,757)	(11,180)
Income tax provision	56	73	168	259
Net loss	$ (4,114)	$ (7,523)	$ (7,925)	$ (11,439)
Net loss per share— Basic	$ (0.30)	$ (0.55)	$ (0.57)	$ (0.83)
Average shares outstanding— Basic	13,895	13,800	13,867	13,777
Net loss per share— Diluted	$ (0.30)	$ (0.55)	$ (0.57)	$ (0.83)
Average shares outstanding— Diluted	13,895	13,800	13,867	13,777

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Statement Of Income And Comprehensive Income [Abstract]
Net loss	$ (4,114)	$ (7,523)	$ (7,925)	$ (11,439)
Foreign currency translation adjustments	(2)		(4)	2
Comprehensive loss	$ (4,116)	$ (7,523)	$ (7,929)	$ (11,437)

CONSOLIDATED STATEMENTS OF STOC

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning Balance at Jan. 28, 2017	$ 61,150	$ 140	$ 105,775	$ (44,693)	$ (72)
Beginning Balance, shares at Jan. 28, 2017		14,010
Net loss	(11,439)			(11,439)
Foreign currency translation adjustments	2				2
Dividends forfeited	15			15
Stock-based compensation	858	$ 6	852
Stock-based compensation, shares		616
Repurchase and retirement of common stock	(45)		(45)
Repurchase and retirement of common stock, shares		(15)
Ending Balance at Oct. 28, 2017	50,541	$ 146	106,582	(56,117)	(70)
Ending Balance, shares at Oct. 28, 2017		14,611
Beginning Balance at Feb. 03, 2018	40,668	$ 147	106,865	(66,274)	(70)
Beginning Balance, shares at Feb. 03, 2018		14,684
Net loss	(7,925)			(7,925)
Foreign currency translation adjustments	(4)				(4)
Dividends forfeited	7			7
Stock-based compensation	750	$ 5	745
Stock-based compensation, shares		477
Exercise of stock options, net	1	$ 0	1
Exercise of stock options, shares		0
Repurchase and retirement of common stock	(136)	$ (7)	(129)
Repurchase and retirement of common stock, shares		(683)
Ending Balance at Nov. 03, 2018	$ 33,361	$ 145	$ 107,482	$ (74,192)	$ (74)
Ending Balance, shares at Nov. 03, 2018		14,478

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017
Operating Activities
Net loss	$ (7,925)	$ (11,439)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	11,789	13,259
Stock-based compensation expense	750	858
Loss on impairment of long-lived assets	2,236	3,267
Loss on disposal of assets	238	283
Grow NJ award benefit	(1,977)	1,096
Amortization of deferred financing costs	506	375
Decrease (increase) in:
Trade receivables	(569)	(1,218)
Inventories	(7,798)	(4,896)
Prepaid expenses and other current assets	1,251	3,110
Other non-current assets	35	(59)
(Decrease) increase in:
Accounts payable, accrued expenses and other current liabilities	(3,861)	2,474
Deferred rent and other non-current liabilities	(2,087)	23
Net cash provided by (used in) operating activities	(7,412)	7,133
Investing Activities
Capital expenditures	(3,456)	(5,484)
Additions to intangible assets		(18)
Net cash used in investing activities	(3,456)	(5,502)
Financing Activities
Decrease in cash overdraft	(1,486)	(461)
Increase in line of credit borrowings	13,700	3,600
Proceeds from long-term debt	2,500	3,401
Repayment of long-term debt	(3,935)	(8,493)
Deferred financing costs paid	(160)	(277)
Withholding taxes on stock-based compensation paid in connection with repurchase of common stock	(136)	(45)
Proceeds from exercise of stock options	1
Net cash provided by (used in) financing activities	10,484	(2,275)
Effect of exchange rate changes on cash and cash equivalents	(4)	2
Net Decrease in Cash and Cash Equivalents	(388)	(642)
Cash and Cash Equivalents, Beginning of Period	1,635	2,859
Cash and Cash Equivalents, End of Period	1,247	2,217
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	2,997	2,640
Cash (received) paid for income taxes	$ 118	$ (4,240)

Basis of Financial Statement Pr

Basis of Financial Statement Presentation	9 Months Ended
	Nov. 03, 2018
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Basis of Financial Statement Presentation	1. BASIS OF FINANCIAL STATEMENT PRESENTATION The accompanying unaudited consolidated financial statements for the three and nine months ended November 3, 2018 and October 28, 2017 have been prepared in accordance with the requirements for Form 10-Q and Article 10 of Regulation S-X, and accordingly, certain information and footnote disclosures have been condensed or omitted. See the Company’s Annual Report on Form 10-K as of and for the year ended February 3, 2018 for Destination Maternity Corporation and subsidiaries (the “Company” or “Destination Maternity”) as filed with the Securities and Exchange Commission (“SEC”) for additional disclosures including a summary of the Company’s accounting policies. In the opinion of management, the consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, necessary to present fairly the consolidated financial position, results of operations and cash flows of the Company for the periods presented. Since the Company’s operations are seasonal, the interim operating results of the Company may not be indicative of operating results for the full year. Certain prior year amounts have been reclassified to conform to the current year presentation. The Company operates on a 52/53-week fiscal year ending on the Saturday nearest January 31 of each year. References to the Company’s fiscal 2018 refer to the 52-week fiscal year, or periods within such fiscal year, which began February 4, 2018 and will end February 2, 2019. References to the Company’s fiscal 2017 refer to the 53-week fiscal year, or periods within such fiscal year, which began January 29, 2017 and ended February 3, 2018.

Earnings Per Share ("EPS") and

Earnings Per Share ("EPS") and Dividends	9 Months Ended
	Nov. 03, 2018
Earnings Per Share [Abstract]
Earnings Per Share ("EPS") and Dividends	2. EARNINGS PER SHARE (“EPS”) AND DIVIDENDS Basic net loss per share (“Basic EPS”) is computed by dividing net loss by the weighted average number of common shares outstanding, excluding restricted stock awards for which the restrictions have not lapsed. Diluted net loss per share (“Diluted EPS”) is computed by dividing net loss by the weighted average number of common shares outstanding, after giving effect to the potential dilution, if applicable, from the assumed lapse of restrictions on restricted stock and restricted stock unit (“RSU”) awards, and from shares of common stock resulting from the assumed exercise of outstanding stock options. Common shares issuable in connection with the award of performance-based restricted stock units (“PRSUs”) are excluded from the calculation of EPS until the PRSUs’ performance conditions are achieved and the shares in respect of the PRSUs become issuable (see Note 13). The following tables summarize the Basic EPS and Diluted EPS calculations (in thousands, except per share amounts): Three Months Ended November 3, 2018 October 28, 2017 Net Loss Shares EPS Net Loss Shares EPS Basic and Diluted EPS $ (4,114 ) 13,895 $ (0.30 ) $ (7,523 ) 13,800 $ (0.55 ) Nine Months Ended November 3, 2018 October 28, 2017 Net Loss Shares EPS Net Loss Shares EPS Basic and Diluted EPS $ (7,925 ) 13,867 $ (0.57 ) $ (11,439 ) 13,777 $ (0.83 ) In addition to PRSUs, for the three and nine months ended November 3, 2018 stock options and unvested restricted stock totaling approximately 436,000 and 804,000 shares, respectively, were excluded from the calculation of Diluted EPS as their effect would have been antidilutive. Stock options and unvested restricted stock totaling approximately 1,130,000 and 1,604,000 shares of the Company’s common stock were outstanding as of November 3, 2018 and October 28, 2017, respectively, but were not included in the computation of Diluted EPS for the three and nine months ended November 3, 2018 and October 28, 2017 due to the Company’s net loss. If the Company had reported a profit for the three and nine months ended November 3, 2018 and for the three and nine months ended October 28, 2017 the weighted average number of dilutive shares outstanding for computation of Diluted EPS would have been approximately 14,186,000, 14,159,000, 13,811,000 and 13,797,000 shares, respectively. During the nine months ended November 3, 2018 and October 28, 2017, $7,000 and $15,000, respectively, of previously declared and undistributed dividends, for which payment was subject to completion of service requirements under restricted stock awards, were forfeited back to the Company in connection with the cancellation of the restricted stock awards.

Trade Receivables

Trade Receivables	9 Months Ended
	Nov. 03, 2018
Receivables [Abstract]
Trade Receivables	3. TRADE RECEIVABLES Trade receivables are recorded based on revenue recognized for sales of the Company’s merchandise and for other revenue earned by the Company through its marketing partnership programs and international franchise agreements, and are non-interest bearing. The Company evaluates the collectability of trade receivables based on a combination of factors, including aging of trade receivables, write-off experience, analysis of historical trends and expectations of future performance. An allowance for doubtful accounts is recorded for the amount of trade receivables that are considered unlikely to be collected. When the Company’s collection efforts are unsuccessful, uncollectible trade receivables are charged against the allowance for doubtful accounts. As of November 3, 2018, and February 3, 2018 the Company’s trade receivables were net of allowance for doubtful accounts of $166,000 and $166,000, respectively.

Inventories

Inventories	9 Months Ended
	Nov. 03, 2018
Inventory Disclosure [Abstract]
Inventories	4. INVENTORIES Inventories were comprised of the following (in thousands): November 3, 2018 February 3, 2018 Finished goods $ 78,711 $ 70,687 Work-in-progress 142 182 Raw materials 201 387 $ 79,054 $ 71,256

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	9 Months Ended
	Nov. 03, 2018
Payables And Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	5. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accrued expenses and other current liabilities were comprised of the following (in thousands): November 3, 2018 February 3, 2018 Employee compensation and benefits $ 6,256 $ 7,133 Accrued expenses 4,866 3,244 Insurance, primarily self-insurance reserves 3,858 5,048 Deferred rent 2,983 3,211 Sales and use taxes 2,827 2,638 Gift certificates and store credits 2,832 3,385 Product return reserve 2,298 2,799 Deferred revenue 1,668 1,001 Audit and legal 1,399 714 Accrued property and equipment additions 185 218 Other 1,816 2,270 $ 30,988 $ 31,661

Line of Credit

Line of Credit	9 Months Ended
	Nov. 03, 2018
Debt Disclosure [Abstract]
Line of Credit	6. LINE OF CREDIT After completion of a debt refinancing on February 1, 2018 the Company has in place a $50,000,000 senior secured revolving credit facility (the “Credit Facility”), which was amended and restated in connection with the issuance of the Company’s $25,000,000 Term Loan (see Note 7). The Company’s previous $70,000,000 Credit Facility had been in place since March 25, 2016. In connection with the Term Loan financing the maturity date of the Credit Facility was extended to January 31, 2023 and certain availability reserves were reduced or eliminated. Proceeds from advances under the Credit Facility, subject to certain restrictions, may be used to provide financing for working capital, letters of credit, capital expenditures, and other general corporate purposes. The Credit Facility contains various affirmative and negative covenants and representations and warranties including the requirement that the Company maintain Excess Availability (as defined in the related Credit Agreement) of more than the greater of 10% of the Combined Loan Caps (as defined in the related Credit Agreement) and $7,000,000. In the event that the outstanding balance of the Term Loan exceeds the Term Loan Borrowing Base (as defined in the related Term Loan Agreement) then a reserve will be imposed against availability under the Credit Facility. The Credit Facility is secured by a security interest in the Company’s trade receivables, inventory, letter of credit rights, cash, intangibles and certain other assets. The interest rate on outstanding borrowings is equal to, at the Company’s election, either 1) the lender’s base rate plus 0.50% or 2) a LIBOR rate plus 1.0%. The Company also pays an unused line fee under the Credit Facility of 0.25% per annum. Any amounts outstanding under the Credit Facility may be accelerated and become due and payable immediately and all loan and letter of credit commitments thereunder may be terminated upon an event of default and expiration of any applicable cure period. Events of default include: 1) nonpayment of obligations due under the subject loan agreement and related loan documents, 2) cross-defaults to other indebtedness and documents, 3) failure to perform any covenant or agreement contained in the subject loan agreement, 4) material misrepresentations, 5) failure to pay, or certain other defaults under, other material indebtedness of the Company, 6) certain bankruptcy or insolvency events, 7) a change of control, 8) indictments of the Company or senior management in a material forfeiture action, 9) default under certain material contracts to the extent such termination or default has or could reasonably be expected to have a material adverse effect, and 10) customary ERISA defaults, among others. In connection with the original execution and subsequent amendments of the Credit Facility, the Company incurred deferred financing costs of $1,280,000. These deferred financing costs are being amortized over the term of the Credit Facility agreement and are included in “interest expense, net” in the consolidated statements of operations. As of November 3, 2018, the Company had $21,700,000 in outstanding borrowings under the Credit Facility, $7,327,000 in letters of credit and $13,505,000 of availability based on the Company’s Borrowing Base formula and availability reserve requirements. As of October 28, 2017, the Company had $8,200,000 in outstanding borrowings under the previous Credit Facility, $7,327,000 in letters of credit and $12,531,000 of availability. For the three months ended November 3, 2018 and October 28, 2017 borrowings had a weighted interest rate of 4.22% and 3.87% per annum, respectively. For the nine months ended November 3, 2018 and October 28, 2017 borrowings had a weighted interest rate of 4.11% and 3.51% per annum, respectively. During the nine months ended November 3, 2018 and October 28, 2017 the Company’s average levels of direct borrowings were $17,258,000 and $8,707,000, respectively, and the Company’s maximum borrowings were $27,400,000 and $15,700,000, respectively. On September 26, 2018, the Company entered into a commitment letter with Bank of America N.A. (“Bank of America”),, pursuant to which, and subject to the terms and conditions set forth therein, Bank of America committed to provide to the Company certain five-year asset-based senior secured facilities consisting of an ABL with an aggregate commitment of $52 million and a FILO Term Loan with an aggregate principal amount of $24 million. The interest rates are expected to be, at the Company’s option, adjusted LIBOR or base rate plus an applicable margin based on excess availability. Such applicable margins for the base rate loans expect to range between 0.50% and 1.00% per annum in the case of the ABL and between 2.25% and 2.75% per annum in the case of the FILO Term Loan. Such applicable margins for the LIBOR loans expect to range between 1.5% to 2.0% in the case of the ABL and between 3.25% to 3.75% in the case of the FILO Term Loan. The funding of the senior secured facilities under the commitment letter is contingent upon the satisfaction of customary conditions, including, but not limited to, the parties’ entering into definitive documentation, absence of material adverse events or conditions with respect to the Company and the receipt of payoff letters in respect of the Company’s existing credit agreements governing its outstanding indebtedness. It is anticipated that the Company will use the net proceeds of the senior secured facilities to repay outstanding indebtedness under its Term Loan previously discussed in this Note 7 and under its Credit Facility previously discussed in Note 6, pay a portion of the transaction fees and expenses in connection with entering into the senior secured facilities and to the extent any net proceeds remain, for ongoing working capital and other general corporate purposes of the Company.

Long-Term Debt

Long-Term Debt	9 Months Ended
	Nov. 03, 2018
Debt Disclosure [Abstract]
Long-Term Debt	7. LONG-TERM DEBT On February 1, 2018 (the “Closing Date”) the Company entered into a Term Loan Credit Agreement (the “Term Loan Agreement”) which provides for a term loan of up to $25,000,000 and matures on January 31, 2023 (the “Term Loan”). On the Closing Date the Company borrowed $22,500,000 net of fees against the Term Loan and used the proceeds, in addition to $3,600,000 borrowed under its Credit Facility (see Note 6) to pay off the $22,999,000 balance of the Company’s then existing term loan (the “Prior Term Loan”) and $3,226,000 of fees and interest associated with the refinancing transaction. The Term Loan provided for an additional loan of $2,500,000 which could be borrowed at the Company’s discretion within a period of 45 days after delivery to the lender of the Company’s first quarter fiscal 2018 financial statements and satisfaction of certain other requirements. The Company met these requirements and borrowed the additional $2,500,000 on July 16, 2018. There is a minimum excess availability requirement of the greater of 10% of the Combined Loan Cap, as defined in the Term Loan Agreement, or $7,000,000. The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%. The Company is required to make minimum repayments of the principal amount of the Term Loan in quarterly installments of $312,500 which commenced on July 31, 2018, with the remaining outstanding balance payable on the maturity date. Additionally, the Term Loan can be prepaid at the Company's option subject to certain restrictions and subject to a prepayment premium as follows: 1) if the prepayment occurs on or prior to the second anniversary of the Closing Date, the greater of a) interest on the prepayment that would otherwise have been paid with the 24 month period following the Closing Date minus actual interest payments made through the prepayment date and b) 2% of the prepayment and 2) 2% of the prepayment amount if paid between the second and third anniversary of the Closing Date. The Term Loan is secured by a security interest in substantially all of the assets of the Company, including accounts receivable, inventory, equipment, letter of credit rights, cash, intellectual property and other intangibles, and certain other assets. The security interest granted to the Term Lenders is, in certain respects, subordinate to the security interest granted to the Credit Facility Lender. The Term Loan Agreement prohibits the payment of dividends or share repurchases by the Company for three years and imposes certain restrictions on the Company's ability to, among other things, incur additional indebtedness and enter into other various types of transactions. On September 26, 2018, the Company entered into a commitment letter with Bank of America, pursuant to which, and subject to the terms and conditions set forth therein, Bank of America committed to provide to the Company certain five-year asset-based senior secured facilities consisting of an ABL with an aggregate commitment of $52 million and a FILO Term Loan with an aggregate principal amount of $24 million. The interest rates are expected to be, at the Company’s option, adjusted LIBOR or base rate plus an applicable margin based on excess availability. Such applicable margins for the base rate loans expect to range between 0.50% and 1.00% per annum in the case of the ABL and between 2.25% and 2.75% per annum in the case of the FILO Term Loan. Such applicable margins for the LIBOR loans expect to range between 1.5% to 2.0% in the case of the ABL and between 3.25% to 3.75% in the case of the FILO Term Loan. The funding of the senior secured facilities under the commitment letter is contingent upon the satisfaction of customary conditions, including, but not limited to, the parties’ entering into definitive documentation, absence of material adverse events or conditions with respect to the Company and the receipt of payoff letters in respect of the Company’s existing credit agreements governing its outstanding indebtedness. It is anticipated that the Company will use the net proceeds of the senior secured facilities to repay outstanding indebtedness under its Term Loan previously discussed in this Note 7 and under its Credit Facility previously discussed in Note 6, pay a portion of the transaction fees and expenses in connection with entering into the senior secured facilities and to the extent any net proceeds remain, for ongoing working capital and other general corporate purposes of the Company. On March 25, 2016 the Company entered into a Term Loan Agreement Credit Agreement (the “Prior Term Loan Agreement”) for the Company’s $32,000,000 Prior Term Loan that had a maturity date of March 25, 2021. The proceeds of the Prior Term Loan were used to repay a portion of the indebtedness that was outstanding under the Company’s credit facility at that time. The interest rate on the Prior Term Loan was equal to a LIBOR rate (with a 1.0% LIBOR floor) plus 7.5%. The Company was required to make minimum repayments of the principal amount in quarterly installments of $800,000 with the remaining outstanding balance payable on the maturity date. As amended on December 19, 2016 and April 7, 2017, the Prior Term Loan Agreement contained various minimum excess availability requirements including $5,000,000 against availability under the Company Credit Facility that was reduced dollar for dollar for prepayments of the Prior Term Loan, and an amount equal to the greater of 10% of the Combined Loan Cap (as defined in the Credit Facility Agreement) or $10,000,000. In connection with the execution of the Term Loan Agreement, the Prior Term Loan Agreement and subsequent amendments, the Company incurred deferred financing costs of $4,557,000. Of this amount, the unamortized balance of $1,542,000 in deferred financing costs incurred in connection with the Prior Term Loan were written off upon entering into the Term Loan and charged to loss on extinguishment of debt in the Company consolidated statements of operations. There were $2,460,000 of deferred financing costs incurred in connection with the Term Loan. These deferred financing costs are reflected as a direct deduction from the Term Loan liability in the consolidated balance sheets and are being amortized over the term of the Term Loan Agreement. The amortization is included in “interest expense, net” in the consolidated statements of operations. As of November 3, 2018, and October 28, 2017 there was $24,375,000 and $24,599,000, respectively, of principal outstanding under the Term Loan and Prior Term Loan. As of November 3, 2018, and October 28, 2017 there was $3,730,000 and $7,064,000, respectively, outstanding under a five-year equipment financing arrangement with the Company’s Credit Facility bank. The equipment note bears annual interest at 3.38%, with payments of $272,000 (including interest) due monthly through December 2019. The equipment note is collateralized by substantially all of the material handling equipment at the Company’s distribution facility in Florence, New Jersey. Any amounts outstanding under the equipment note may be accelerated and become due and payable immediately upon an event of default and expiration of any applicable cure period. The specified events of default are substantially the same as those in the Credit Facility agreement (see Note 6). On June 6, 2017 the Company received $3,401,000 in proceeds from a three-year financing arrangement in the form of a sale and leaseback for certain furniture, fixtures and software. Monthly payments under the leaseback arrangement are $123,000 for the first 24 months and $48,000 for months 25 to 36. At the end of the leaseback term, the Company has the option to extend the lease for an additional year or to repurchase the financed property for a price to be agreed. All of the proceeds from the transaction were used to prepay a portion of the Company’s Term Loan. As of November 3, 2018, and October 28, 2017, there was $1,680,000 and $2,947,000 of principal outstanding under this financing arrangement.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Nov. 03, 2018
Fair Value Disclosures [Abstract]
Fair Value Measurements	8. FAIR VALUE MEASUREMENTS The accounting standard for fair value measurements defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard establishes a framework for measuring fair value focused on exit price and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements as follows: • Level 1 – Quoted market prices in active markets for identical assets or liabilities • Level 2 – Observable market-based inputs or inputs that are corroborated by observable market data • Level 3 – Unobservable inputs that are not corroborated by market data At both November 3, 2018 and February 3, 2018, the Company had cash equivalents of $4,000. The Company’s cash equivalents consist of investments in money market funds for which the carrying value approximates fair value (based on Level 1 inputs) due to the short-term nature of those instruments. The carrying values of trade receivables and accounts payable approximate fair value due to the short-term nature of those instruments. The Company’s Credit Facility has variable interest rates that are tied to market indices. As of November 3 , 2018, and February 3, 2018, The Company’s Term Loan, which represents a significant majority of the Company’s long-term debt, bears interest at variable rates, which adjust based on market conditions with a minimum annual rate of 9.00%. The carrying value of the Company’s Term Loan approximates fair value as the variable interest rates approximate current market rates for similar instruments available to companies with comparable credit quality, which the Company considers to be Level 2 inputs. The fair value of the Company’s fixed-rate equipment notes was determined using a discounted cash flow analysis based on interest rates currently available to the Company, which the Company considers to be Level 2 inputs. The difference between the carrying value and fair value of long-term debt held by the Company with a fixed rate of interest is not material.

Net Sales

Net Sales	9 Months Ended
	Nov. 03, 2018
Revenues [Abstract]
Net Sales	9. NET SALES The following disaggregates the Company’s net sales by major source (in thousands): Three Months Ended Nine Months Ended November 3, 2018 October 28, 2017 November 3, 2018 October 28, 2017 Retail stores $ 55,979 $ 59,325 $ 177,608 $ 191,664 Leased departments 9,743 10,292 29,624 32,752 Total retail locations 65,722 69,617 207,232 224,416 Ecommerce 21,045 20,539 69,530 57,615 Marketing partnerships 4,110 4,475 12,236 13,004 Wholesale and franchise 1,960 1,723 3,461 6,025 Total net sales $ 92,837 $ 96,354 $ 292,459 $ 301,060 The Company’s performance obligations consist primarily of transferring control of merchandise to customers. Retail and ecommerce sales are recognized upon transfer of control, which occurs when merchandise is taken at point-of-sale for a retail transaction or upon receipt of shipment for an ecommerce transaction. Sales are reported net of returns and sales taxes. Shipping and handling fees billed to customers are recognized in net sales when control of the underling merchandise is transferred to the customer. The Company earns revenue through a variety of marketing partnership programs utilizing the Company’s opt-in customer database and various in-store marketing initiatives focused on baby and parent-related products and services. Revenue from these activities is recognized when the goods or services are provided. Sales of product to the Company’s wholesale customers and international franchisees are recognized upon transfer of control which is primarily when product is shipped. Franchise fees are recorded by the Company when all material services have been performed or in the case of royalties earned on sales of product, in the period when the franchisee sells product to their retail customer.

Other Charges, Net

Other Charges, Net	9 Months Ended
	Nov. 03, 2018
Other Charges Net Related To Proxy Solicitation And Proposed Merger And Management And Organizational Changes [Abstract]
Other Charges, Net	10 . OTHER CHARGES, NET In the first quarter of fiscal 2018 the Company received notification from a stockholder group (the “Stockholder Group”), of the nomination of a slate of alternative nominees for election to the Company’s Board of Directors at the Annual Meeting of Stockholders that was held on May 23, 2018 (the “Proxy Solicitation”). At the Company’s 2018 Annual Meeting of Stockholders held on May 23, 2018, the Company’s stockholders replaced the incumbent board in its entirety and elected Holly N. Alden, Christopher B. Morgan, Marla A Ryan and Anne-Charlotte Windal as the Company’s new Board of Directors . During the fourth quarter of fiscal 2015 the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with the Company’s largest shareholder, Orchestra, a France-based retailer of children’s wear, to complete a proposed business combination (“the Proposed Merger”). During the second quarter of fiscal 2017 the parties determined that is was in the best interest of their respective stockholders to terminate the Merger and on July 27, 2017, the Company, Orchestra, and certain other affiliates of Orchestra entered into a Termination Agreement (the “Termination Agreement”). In connection with the Termination Agreement, Orchestra and the Company agreed to reimburse each other for certain costs incurred in connection with their effort to implement the Merger Agreement. During the nine months ended October 28, 2017 the Company incurred $1,113,000 of charges related to the proposed merger. O ver the last several years the Company has engaged in a series of management and organizational changes and, in connection therewith, retained consulting firms to review its costs and business strategy associated with such management and organizational changes. The Company’s Board of Directors authorized changes to the Company’s chief executive function including the resignation of Anthony M. Romano as the Company’s Chief Executive Officer and President, the September 17, 2017 appointment of B. Allen Weinstein, an independent member of the Company’s Board since 2010, as Interim Chief Executive Officer replacing Mr. Romano, the January 2, 2018 appointment of Melissa Payner-Gregor, an independent member of the Company’s Board since 2009, as Interim Chief Executive Officer replacing Mr. Weinstein and the May 23, 2018 appointment of Marla Ryan as Chief Executive Officer replacing Ms. Payner-Gregor. Ronald Masciantonio, the Company’s Chief Administrative Officer, resigned from his position on June 4, 2018. David Stern, the Company’s former Chief Financial Officer departed the Company effective at the close of business on August 10, 2018. The Company also paid one-time retention bonuses with service conditions to certain key management personnel which are being recorded over the service period, while reducing its overall headcount to create a more efficient and effective operating structure. A summary of the net charges incurred in connection with the proxy solicitation and proposed merger and the management and organizational changes is as follows (in thousands): Three Months Ended Nine Months Ended November 3, 2018 October 28, 2017 November 3, 2018 October 28, 2017 Proxy Solicitation and Proposed Merger Proxy solicitation $ 83 $ — $ 2,224 $ — Proposed merger — 464 — 1,113 Total proxy solicitation and proposed merger 83 464 2,224 1,113 Management and Organizational Changes Severance and related benefits 1,252 2,139 2,136 2,136 Consulting fees 490 497 538 497 Total management and organizational changes 1,742 2,636 2,674 2,633 Total other charges, net $ 1,825 $ 3,100 $ 4,898 $ 3,746

Government Incentives

Government Incentives	9 Months Ended
	Nov. 03, 2018
Government Incentives Disclosure [Abstract]
Government Incentives	11. GOVERNMENT INCENTIVES In fiscal 2015 the Company completed the relocation of its corporate headquarters and distribution operations from Philadelphia, Pennsylvania to southern New Jersey. To partially offset the costs of these relocations, the Board of the New Jersey Economic Development Authority (“NJEDA”) approved the Company for an incentive package of up to $40,000,000 in benefits under the Grow New Jersey Assistance Program (“Grow NJ”) in the form of transferrable income tax credits over a ten-year period from the State of New Jersey. The award provides annually over a ten-year period up to $7,000 per eligible new full-time job, as defined under Grow NJ, with a requirement that at least 100 eligible jobs be created and subject to an annual award limit of $4,000,000. The Grow NJ award requires an annual compliance report that includes certification of average annual employment figures after the end of each fiscal year. After the end of the ten-year Grow NJ award earnings period there is a five-year compliance period during which the Company must maintain the average of its annual eligible jobs certified during the preceding ten years or a pro-rata amount up to one-tenth of the previously awarded income tax credits would be subject to recapture and repayment to the State of New Jersey annually during the five-year compliance period. The Company believes the likelihood of any recapture and repayment is remote. The annual benefit from the Grow NJ award available to the Company is expected to significantly exceed the Company’s annual income tax liability to the State of New Jersey. In order to maximize the realizable value of the incentive package, in December 2013 the Company entered into an agreement with a third party to sell 75% or more of the annual income tax credits awarded to the Company. The Company recognizes its Grow NJ award on an annual basis for each fiscal year based on the realizable value of the award earned and expected to be received, primarily from the sale of the income tax credits, net of any associated costs. The Grow NJ award is reflected in the Company’s consolidated financial statements as a reduction to the costs incurred by the Company in connection with the relocations. The expected realizable amount of the Grow NJ award is included in the consolidated balance sheet in deferred income taxes. As of November 3, 2018, the Company had recorded a deferred tax asset of $4,805,000 related to the NJ Grow award. Of this amount, $2,829,000 relates to the annual award earned in fiscal 2017, the cash proceeds of which is expected to be received in the fourth quarter of fiscal 2018. In April 2017, the Company received $3,251,000 cash proceeds, net of costs, from the receipt and subsequent sale of the $3,612,000 tax credit certificate earned for fiscal 2016. During the three and nine months ended November 3, 2018, the Company recognized the cost reduction related to the Grow NJ award in the amount of $617,000 and $1,902,000, respectively, as compared to the three and nine months ended October 28, 2017 in which the Company recognized $718,000 and $2,155,000 respectively.

Income Taxes

Income Taxes	9 Months Ended
	Nov. 03, 2018
Income Tax Disclosure [Abstract]
Income Taxes	12. INCOME TAXES The U.S. Tax Cuts and Jobs Act of 2017 (the “TCJA”) was signed into law on December 22, 2017. The TCJA included a number of changes to the U.S. corporate income tax including a reduction of the corporate income tax rate from 35% to 21% for tax years beginning after December 31, 2017. For fiscal 2018 the Company’s effective federal tax rate is 21%. For fiscal 2017 the Company used a blended effective tax rate of 33.7% which represented the prorated percentage from the TCJA’s January 1, 2018 effective date and the Company’s February 3, 2018 fiscal year-end. Accounting Standards Codification (“ASC”) Topic 740, Income Taxes In situations where a three-year cumulative loss condition exists, accounting standards limit the ability to consider projections of future results as positive evidence to assess the realizability of deferred tax assets. In fiscal 2016 the Company’s financial results reflected a three-year cumulative loss. Consequently, in fiscal 2016 the Company recorded a non-cash charge as a valuation allowance against substantially all of its deferred tax assets. Three-year cumulative losses have continued in fiscal 2017 and fiscal 2018, consequently the Company continues to record a valuation allowance against its deferred tax assets.

Equity Award Plans

Equity Award Plans	9 Months Ended
	Nov. 03, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Equity Award Plans	13. EQUITY AWARD PLANS In January 2006, the stockholders of the Company approved the adoption of the Amended and Restated 2005 Equity Incentive Plan (the “2005 Plan”) and, subsequently, have approved amendments to increase the number of issuable shares under the 2015 Plan. Under the 2005 Plan, employees, directors, consultants and other individuals who provide services to the Company may be granted awards in the form of stock options, stock appreciation rights, restricted stock, RSU’s or deferred stock units. Up to 3,550,000 shares of the Company’s common stock may be issued in respect of awards under the 2005 Plan, as amended, with no more than 2,250,000 of those shares permitted to be issued in respect of restricted stock, RSU’s, or deferred stock units granted under the 2005 Plan. Awards of stock options to purchase the Company’s common stock will have exercise prices as determined by the Compensation Committee of the Board of Directors (the “Compensation Committee”), but such exercise prices may not be lower than the fair market value of the stock on the date of grant. No stock options have been granted by the Company with an exercise price less than the fair market value of the Company’s common stock on the date of grant for any of the periods presented. The majority of the stock options issued under the 2005 Plan vest ratably over four-year periods and generally expire ten years from the date of grant. Restricted stock and time-based RSU awards issued under the 2005 Plan generally have restrictions that lapse ratably over periods ranging from one to four years however, up to 177,500 restricted stock awards may be issued with a vesting period of less than one year. Performance-based awards issued under the 2005 Plan generally vest based upon the achievement of pre-established performance goals over a specified three-year period. The number of shares of our common stock that may be earned in respect of performance-based awards may be greater or less than the target number of shares granted based on the actual performance achieved. The non-executive chairman of the Company’s Board of Directors is granted 6,000 shares of restricted stock on an annual bases and each non-employee director, other than the non-executive chairman, of the Company’s Board of Directors is granted 4,000 shares of restricted stock on an annual basis, in each case that will vest one year from the date of grant. The Company issues new shares of common stock upon exercise of vested stock options. As of November 3, 2018, there were 896,848 shares of the Company’s common stock available for grant under the 2005 Plan in the form of stock options, restricted stock, RSUs or deferred stock units. Stock option activity for all plans was as follows: Outstanding Stock Options (in thousands) Weighted Average Exercise Price Weighted Average Remaining Life Aggregate Intrinsic Value (in thousands) Balance as of February 3, 2018 544 $ 11.26 Granted 464 3.06 Exercised — — Forfeited (483 ) 8.44 Expired — — Balance as of November 3, 2018 525 $ 6.62 8.4 $ 598 Exercisable as of November 3, 2018 179 $ 11.35 6.6 — The following table summarizes information about stock options outstanding as of November 3, 2018: Stock Options Outstanding Stock Options Exercisable Range of Exercise Prices Number Outstanding (in thousands) Weighted Average Remaining Life Weighted Average Exercise Price Number Exercisable (in thousands) Weighted Average Exercise Price $ 2.65 to $ 5.00 224 9.5 $ 2.65 — $ - 5.01 to 10.00 199 8.4 6.36 91 6.74 10.01 to 31.38 102 5.8 15.82 88 16.16 $ 2.65 to $31.38 525 8.4 $ 6.62 179 $ 11.35 The following table summarizes information about restricted stock and RSU activity for the 2005 Plan and includes 75,471 performance-based RSUs which is the number of RSUs that would be delivered if the target level of performance is achieved. If performance was achieved at the maximum level, 150,942 RSUs would be delivered. Outstanding Restricted Shares (in thousands) Weighted Average Grant Date Fair Value Unvested as of February 3, 2018 853 $ 3.16 Granted 545 3.38 Vested (144 ) 3.81 Forfeited (649 ) 2.89 Unvested as of November 3, 2018 605 $ 3.49

Recent Accounting Pronouncement

Recent Accounting Pronouncements and Change in Accounting Principle	9 Months Ended
	Nov. 03, 2018
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]
Recent Accounting Pronouncements and Change in Accounting Principle	14. RECENT ACCOUNTING PRONOUNCEMENTS AND CHANGE IN ACCOUNTING PRINCIPLE a. Newly Adopted Accounting Pronouncements In May 2017 the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting In October 2016 the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory In August 2016 the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments In May 2014 the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date Management adopted this guidance on February 3, 2018 using the modified retrospective approach. This ASU required that sales return reserves be presented on a gross basis as a refund liability and an asset for recovery and that the asset be reported separate from inventory on the Company’s consolidated balance sheet. Prior to the adoption of this ASU the Company had recorded its sales return reserve on a gross basis with the asset for recovery recorded as a component of inventory. The impact of adoption on the Company’s consolidated balance sheet as of November 3, 2018 is as follows: Excluding ASU (in thousands) As Reported ASU 2014-09 Effect 2014-09 Effect Inventories $ 79,054 $ (1,070 ) 77,984 Prepaid expenses and other current assets 10,270 1,070 11,340 There was no impact from adoption on the Company’s consolidated statements of operations or consolidated statements of cash flow. b. Not Yet Adopted In February 2016 the FASB issued ASU No. 2016-02, Leases (Topic 842) Leases While the Company is still evaluating this standard, given the significant number of leases the Company is party to, the Company expects this standard will have a material impact on the Company's consolidated financial statements. The standard will have no impact on our debt-covenant compliance under our current agreements. In August 2018, the FASB issued ASU 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Nov. 03, 2018
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	15. COMMITMENTS AND CONTINGENCIES From time to time, the Company is named as a defendant in legal actions arising from normal business activities. Litigation is inherently unpredictable, and although the amount of any liability that could arise with respect to currently pending actions cannot be accurately predicted, the Company does not believe that the resolution of any pending action will have a material adverse effect on its financial position, results of operations or liquidity.

Segment and Enterprise Wide Dis

Segment and Enterprise Wide Disclosures	9 Months Ended
	Nov. 03, 2018
Segment Reporting [Abstract]
Segment and Enterprise Wide Disclosures	16. SEGMENT AND ENTERPRISE WIDE DISCLOSURES Operating Segment . For purposes of the disclosure requirements for segments of a business enterprise, the Company has determined that its business is comprised of one operating segment: the design, manufacture and sale of maternity apparel and related accessories. While the Company offers a wide range of products for sale, the substantial portion of its products are initially distributed through the same distribution facilities, many of the Company’s products are manufactured at common contract manufacturer production facilities, the Company’s products are marketed through a common marketing department, and these products are sold to a similar customer base consisting of expectant mothers. Geographic Information . Geographic revenue information is allocated based on the country in which the products or services are sold, and in the case of international franchise revenues, on the location of the customer. Information concerning the Company’s operations by geographic area was as follows (in thousands): Three Months Ended Nine Months Ended November 3, 2018 October 28, 2017 November 3, 2018 October 28, 2017 Net Sales United States $ 88,006 $ 90,584 $ 278,057 $ 283,676 Foreign 4,831 5,770 14,402 17,384 November 3, 2018 February 3, 2018 Long-Lived Assets United States $ 54,696 $ 65,456 Foreign 1,325 1,643 Major Customers . For the periods presented, the Company did not have any one customer who represented more than 10% of its net sales.

Interest Expense, Net

Interest Expense, Net	9 Months Ended
	Nov. 03, 2018
Banking And Thrift Interest [Abstract]
Interest Expense, Net	17. INTEREST EXPENSE, NET Interest expense, net was comprised of the following (in thousands): Three Months Ended Nine Months Ended November 3, 2018 October 28, 2017 November 3, 2018 October 28, 2017 Interest expense $ 1,233 $ 1,006 $ 3,535 $ 2,991 Interest income (1 ) - (2 ) (2 ) Interest expense, net $ 1,232 $ 1,006 $ 3,533 $ 2,989

Recent Accounting Pronounceme_2

Recent Accounting Pronouncements and Change in Accounting Principle (Policies)	9 Months Ended
	Nov. 03, 2018
Accounting Policies [Abstract]
Newly Adopted Accounting Pronouncements	a. Newly Adopted Accounting Pronouncements In May 2017 the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-09, Compensation - Stock Compensation (Topic 718): Scope of Modification Accounting In October 2016 the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory In August 2016 the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments In May 2014 the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date Management adopted this guidance on February 3, 2018 using the modified retrospective approach. This ASU required that sales return reserves be presented on a gross basis as a refund liability and an asset for recovery and that the asset be reported separate from inventory on the Company’s consolidated balance sheet. Prior to the adoption of this ASU the Company had recorded its sales return reserve on a gross basis with the asset for recovery recorded as a component of inventory. The impact of adoption on the Company’s consolidated balance sheet as of November 3, 2018 is as follows: Excluding ASU (in thousands) As Reported ASU 2014-09 Effect 2014-09 Effect Inventories $ 79,054 $ (1,070 ) 77,984 Prepaid expenses and other current assets 10,270 1,070 11,340 There was no impact from adoption on the Company’s consolidated statements of operations or consolidated statements of cash flow.
Not Yet Adopted	b. Not Yet Adopted In February 2016 the FASB issued ASU No. 2016-02, Leases (Topic 842) Leases While the Company is still evaluating this standard, given the significant number of leases the Company is party to, the Company expects this standard will have a material impact on the Company's consolidated financial statements. The standard will have no impact on our debt-covenant compliance under our current agreements. In August 2018, the FASB issued ASU 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract

Earnings Per Share ("EPS") an_2

Earnings Per Share ("EPS") and Dividends (Tables)	9 Months Ended
	Nov. 03, 2018
Earnings Per Share [Abstract]
Summary of Basic EPS and Diluted EPS Calculations	The following tables summarize the Basic EPS and Diluted EPS calculations (in thousands, except per share amounts): Three Months Ended November 3, 2018 October 28, 2017 Net Loss Shares EPS Net Loss Shares EPS Basic and Diluted EPS $ (4,114 ) 13,895 $ (0.30 ) $ (7,523 ) 13,800 $ (0.55 ) Nine Months Ended November 3, 2018 October 28, 2017 Net Loss Shares EPS Net Loss Shares EPS Basic and Diluted EPS $ (7,925 ) 13,867 $ (0.57 ) $ (11,439 ) 13,777 $ (0.83 )

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Nov. 03, 2018
Inventory Disclosure [Abstract]
Inventories	Inventories were comprised of the following (in thousands): November 3, 2018 February 3, 2018 Finished goods $ 78,711 $ 70,687 Work-in-progress 142 182 Raw materials 201 387 $ 79,054 $ 71,256

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Nov. 03, 2018
Payables And Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities were comprised of the following (in thousands): November 3, 2018 February 3, 2018 Employee compensation and benefits $ 6,256 $ 7,133 Accrued expenses 4,866 3,244 Insurance, primarily self-insurance reserves 3,858 5,048 Deferred rent 2,983 3,211 Sales and use taxes 2,827 2,638 Gift certificates and store credits 2,832 3,385 Product return reserve 2,298 2,799 Deferred revenue 1,668 1,001 Audit and legal 1,399 714 Accrued property and equipment additions 185 218 Other 1,816 2,270 $ 30,988 $ 31,661

Net Sales (Tables)

Net Sales (Tables)	9 Months Ended
	Nov. 03, 2018
Revenues [Abstract]
Schedule of Disaggregation of Company's Net Sales by Major Source	The following disaggregates the Company’s net sales by major source (in thousands): Three Months Ended Nine Months Ended November 3, 2018 October 28, 2017 November 3, 2018 October 28, 2017 Retail stores $ 55,979 $ 59,325 $ 177,608 $ 191,664 Leased departments 9,743 10,292 29,624 32,752 Total retail locations 65,722 69,617 207,232 224,416 Ecommerce 21,045 20,539 69,530 57,615 Marketing partnerships 4,110 4,475 12,236 13,004 Wholesale and franchise 1,960 1,723 3,461 6,025 Total net sales $ 92,837 $ 96,354 $ 292,459 $ 301,060

Other Charges, Net (Tables)

Other Charges, Net (Tables)	9 Months Ended
	Nov. 03, 2018
Other Charges Net Related To Proxy Solicitation And Proposed Merger And Management And Organizational Changes [Abstract]
Summary of Net Charges Incurred in Proxy Solicitation and Proposed Merger and Management and Organizational Changes	A summary of the net charges incurred in connection with the proxy solicitation and proposed merger and the management and organizational changes is as follows (in thousands): Three Months Ended Nine Months Ended November 3, 2018 October 28, 2017 November 3, 2018 October 28, 2017 Proxy Solicitation and Proposed Merger Proxy solicitation $ 83 $ — $ 2,224 $ — Proposed merger — 464 — 1,113 Total proxy solicitation and proposed merger 83 464 2,224 1,113 Management and Organizational Changes Severance and related benefits 1,252 2,139 2,136 2,136 Consulting fees 490 497 538 497 Total management and organizational changes 1,742 2,636 2,674 2,633 Total other charges, net $ 1,825 $ 3,100 $ 4,898 $ 3,746

Equity Award Plans (Tables)

Equity Award Plans (Tables)	9 Months Ended
	Nov. 03, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Option Activity for All Plans	Stock option activity for all plans was as follows: Outstanding Stock Options (in thousands) Weighted Average Exercise Price Weighted Average Remaining Life Aggregate Intrinsic Value (in thousands) Balance as of February 3, 2018 544 $ 11.26 Granted 464 3.06 Exercised — — Forfeited (483 ) 8.44 Expired — — Balance as of November 3, 2018 525 $ 6.62 8.4 $ 598 Exercisable as of November 3, 2018 179 $ 11.35 6.6 —
Summarizes Information about Stock Options Outstanding	The following table summarizes information about stock options outstanding as of November 3, 2018: Stock Options Outstanding Stock Options Exercisable Range of Exercise Prices Number Outstanding (in thousands) Weighted Average Remaining Life Weighted Average Exercise Price Number Exercisable (in thousands) Weighted Average Exercise Price $ 2.65 to $ 5.00 224 9.5 $ 2.65 — $ - 5.01 to 10.00 199 8.4 6.36 91 6.74 10.01 to 31.38 102 5.8 15.82 88 16.16 $ 2.65 to $31.38 525 8.4 $ 6.62 179 $ 11.35
Restricted Stock Activity	The following table summarizes information about restricted stock and RSU activity for the 2005 Plan and includes 75,471 performance-based RSUs which is the number of RSUs that would be delivered if the target level of performance is achieved. If performance was achieved at the maximum level, 150,942 RSUs would be delivered. Outstanding Restricted Shares (in thousands) Weighted Average Grant Date Fair Value Unvested as of February 3, 2018 853 $ 3.16 Granted 545 3.38 Vested (144 ) 3.81 Forfeited (649 ) 2.89 Unvested as of November 3, 2018 605 $ 3.49

Recent Accounting Pronounceme_3

Recent Accounting Pronouncements and Change in Accounting Principle (Tables)	9 Months Ended
	Nov. 03, 2018
ASU 2014-09
Impact of Adoption on Consolidated Balance Sheet	The impact of adoption on the Company’s consolidated balance sheet as of November 3, 2018 is as follows: Excluding ASU (in thousands) As Reported ASU 2014-09 Effect 2014-09 Effect Inventories $ 79,054 $ (1,070 ) 77,984 Prepaid expenses and other current assets 10,270 1,070 11,340

Segment and Enterprise Wide D_2

Segment and Enterprise Wide Disclosures (Tables)	9 Months Ended
	Nov. 03, 2018
Segment Reporting [Abstract]
Operations by Geographic Area	Geographic Information . Geographic revenue information is allocated based on the country in which the products or services are sold, and in the case of international franchise revenues, on the location of the customer. Information concerning the Company’s operations by geographic area was as follows (in thousands): Three Months Ended Nine Months Ended November 3, 2018 October 28, 2017 November 3, 2018 October 28, 2017 Net Sales United States $ 88,006 $ 90,584 $ 278,057 $ 283,676 Foreign 4,831 5,770 14,402 17,384 November 3, 2018 February 3, 2018 Long-Lived Assets United States $ 54,696 $ 65,456 Foreign 1,325 1,643

Interest Expense, Net (Tables)

Interest Expense, Net (Tables)	9 Months Ended
	Nov. 03, 2018
Banking And Thrift Interest [Abstract]
Interest Expense, Net	Interest expense, net was comprised of the following (in thousands): Three Months Ended Nine Months Ended November 3, 2018 October 28, 2017 November 3, 2018 October 28, 2017 Interest expense $ 1,233 $ 1,006 $ 3,535 $ 2,991 Interest income (1 ) - (2 ) (2 ) Interest expense, net $ 1,232 $ 1,006 $ 3,533 $ 2,989

Earnings Per Share ("EPS") an_3

Earnings Per Share ("EPS") and Dividends - Summary of Basic EPS and Diluted EPS Calculations (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Earnings Per Share [Abstract]
Net Loss	$ (4,114)	$ (7,523)	$ (7,925)	$ (11,439)
Basic and Diluted shares	13,895	13,800	13,867	13,777
Basic and Diluted EPS	$ (0.30)	$ (0.55)	$ (0.57)	$ (0.83)

Earnings Per Share ("EPS") an_4

Earnings Per Share ("EPS") and Dividends - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Earnings Per Share Diluted [Line Items]
Options and unvested restricted stock	436,000	804,000	1,130,000	1,604,000
Weighted average number of diluted shares outstanding	13,895,000	13,800,000	13,867,000	13,777,000
Dividends forfeited			$ 7	$ 15
Pro Forma
Earnings Per Share Diluted [Line Items]
Weighted average number of diluted shares outstanding	14,186,000	13,811,000	14,159,000	13,797,000

Trade Receivables - Additional

Trade Receivables - Additional Information (Details) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018
Receivables [Abstract]
Trade receivables, allowance for doubtful accounts	$ 166	$ 166

Inventories - Inventories (Deta

Inventories - Inventories (Details) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018
Inventory Disclosure [Abstract]
Finished goods	$ 78,711	$ 70,687
Work-in-progress	142	182
Raw materials	201	387
Total	$ 79,054	$ 71,256

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018
Payables and Accruals [Abstract]
Employee compensation and benefits	$ 6,256	$ 7,133
Accrued expenses	4,866	3,244
Insurance, primarily self-insurance reserves	3,858	5,048
Deferred rent	2,983	3,211
Sales and use taxes	2,827	2,638
Gift certificates and store credits	2,832	3,385
Product return reserve	2,298	2,799
Deferred revenue	1,668	1,001
Audit and legal	1,399	714
Accrued property and equipment additions	185	218
Other	1,816	2,270
Total accrued expenses and other current liabilities	$ 30,988	$ 31,661

Line of Credit - Additional Inf

Line of Credit - Additional Information (Details) - USD ($)	Sep. 26, 2018	Feb. 01, 2018	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017	Feb. 03, 2018	Mar. 25, 2016
Line Of Credit Facility [Line Items]
Minimum excess availability on Combined Loan Cap			10.00%		10.00%
Minimum amount excess availability on Combined Loan Cap			$ 7,000,000		$ 7,000,000
Payment of financing costs					160,000	$ 277,000
Outstanding borrowings under Credit Facility			21,700,000	$ 8,200,000	21,700,000	8,200,000	$ 8,000,000
Letters of credit			7,327,000	7,327,000	7,327,000	7,327,000
Line of credit availability			$ 13,505,000	$ 12,531,000	$ 13,505,000	$ 12,531,000
Borrowings interest rate			4.22%	3.87%	4.11%	3.51%
Line of credit, outstanding borrowings					$ 17,258,000	$ 8,707,000
Line of credit borrowings during period					$ 27,400,000	$ 15,700,000
Asset-based senior secured facilities committed period	5 years
Term Loan
Line Of Credit Facility [Line Items]
Loan available for borrowing		$ 25,000,000
Minimum excess availability on Combined Loan Cap		10.00%
Minimum amount excess availability on Combined Loan Cap		$ 7,000,000
Credit Facility Description of Variable Rate Basis					The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%.
Term Loan | Maximum
Line Of Credit Facility [Line Items]
Loan available for borrowing		$ 25,000,000
Term Loan | London Interbank Offered Rate (LIBOR)
Line Of Credit Facility [Line Items]
Applicable margin rate		9.00%
Senior Secured Revolving Credit Facility
Line Of Credit Facility [Line Items]
Credit facility, maximum borrowing capacity		$ 50,000,000
Unused line fee under the Credit Facility					0.25%
Credit Facility Description of Variable Rate Basis					The interest rate on outstanding borrowings is equal to, at the Company’s election, either 1) the lender’s base rate plus 0.50% or 2) a LIBOR rate plus 1.0%.
Deferred financing costs							$ 1,280,000
Senior Secured Revolving Credit Facility | Base Rate
Line Of Credit Facility [Line Items]
Applicable margin rate					0.50%
Senior Secured Revolving Credit Facility | London Interbank Offered Rate (LIBOR)
Line Of Credit Facility [Line Items]
Applicable margin rate					1.00%
Senior Secured Revolving Credit Facility | Credit Facility
Line Of Credit Facility [Line Items]
Credit facility, maximum borrowing capacity								$ 70,000,000
Senior Secured Revolving Credit Facility | Term Loan
Line Of Credit Facility [Line Items]
Line of credit maturity date extension					Jan. 31, 2023
ABL
Line Of Credit Facility [Line Items]
Credit facility, maximum borrowing capacity	$ 52,000,000
ABL | Base Rate | Minimum
Line Of Credit Facility [Line Items]
Applicable margin rate	0.50%
ABL | Base Rate | Maximum
Line Of Credit Facility [Line Items]
Applicable margin rate	1.00%
ABL | London Interbank Offered Rate (LIBOR) | Minimum
Line Of Credit Facility [Line Items]
Applicable margin rate	1.50%
ABL | London Interbank Offered Rate (LIBOR) | Maximum
Line Of Credit Facility [Line Items]
Applicable margin rate	2.00%
FILO Term Loan
Line Of Credit Facility [Line Items]
Loan available for borrowing	$ 24,000,000
FILO Term Loan | Base Rate | Minimum
Line Of Credit Facility [Line Items]
Applicable margin rate	2.25%
FILO Term Loan | Base Rate | Maximum
Line Of Credit Facility [Line Items]
Applicable margin rate	2.75%
FILO Term Loan | London Interbank Offered Rate (LIBOR) | Minimum
Line Of Credit Facility [Line Items]
Applicable margin rate	3.25%
FILO Term Loan | London Interbank Offered Rate (LIBOR) | Maximum
Line Of Credit Facility [Line Items]
Applicable margin rate	3.75%

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Details) - USD ($)	Sep. 26, 2018	Feb. 01, 2018	Jun. 06, 2017	Mar. 25, 2016	Jan. 31, 2015	Nov. 03, 2018	Oct. 28, 2017	Jul. 16, 2018	Apr. 07, 2017
Debt Instrument [Line Items]
Proceeds from long-term debt						$ 2,500,000	$ 3,401,000
Payments of Financing Costs						$ 160,000	277,000
Minimum excess availability on Combined Loan Cap						10.00%
Minimum amount excess availability on Combined Loan Cap						$ 7,000,000
Asset-based senior secured facilities committed period	5 years
Sale and leaseback, transaction date						June 6, 2017
Sale and leaseback transaction, financing agreement period			3 years
Sale and leaseback, description of assets						certain furniture, fixtures and software
Monthly payments for first 24 months			$ 123,000
Monthly payments under leaseback arrangement for 25 to 36 months			48,000
Sale and leaseback, payment terms						Monthly payments under the leaseback arrangement are $123,000 for the first 24 months and $48,000 for months 25 to 36.
Principal outstanding						$ 1,680,000	2,947,000
Equipment Loan
Debt Instrument [Line Items]
Principal outstanding under equipment note						$ 3,730,000	7,064,000
Equipment financing arrangement period						5 years
Percentage of interest on equipment financing arrangement					3.38%
Monthly payments for equipment financing arrangement					$ 272,000
Debt instrument maturity date					Dec. 31, 2019
ABL
Debt Instrument [Line Items]
Credit facility, maximum borrowing capacity	$ 52,000,000
FILO Term Loan
Debt Instrument [Line Items]
Loan available for borrowing	$ 24,000,000
Minimum | London Interbank Offered Rate (LIBOR) | ABL
Debt Instrument [Line Items]
Applicable margin rate	1.50%
Minimum | London Interbank Offered Rate (LIBOR) | FILO Term Loan
Debt Instrument [Line Items]
Applicable margin rate	3.25%
Minimum | Base Rate | ABL
Debt Instrument [Line Items]
Applicable margin rate	0.50%
Minimum | Base Rate | FILO Term Loan
Debt Instrument [Line Items]
Applicable margin rate	2.25%
Maximum | London Interbank Offered Rate (LIBOR) | ABL
Debt Instrument [Line Items]
Applicable margin rate	2.00%
Maximum | London Interbank Offered Rate (LIBOR) | FILO Term Loan
Debt Instrument [Line Items]
Applicable margin rate	3.75%
Maximum | Base Rate | ABL
Debt Instrument [Line Items]
Applicable margin rate	1.00%
Maximum | Base Rate | FILO Term Loan
Debt Instrument [Line Items]
Applicable margin rate	2.75%
Term Loan
Debt Instrument [Line Items]
Loan available for borrowing		$ 25,000,000
Line of credit maturity date		Jan. 31, 2023
Proceeds from long-term debt		$ 22,500,000
Proceeds from loan		3,600,000
Additional loan available for borrowing		$ 2,500,000
Period of delivery to the lender		45 days
Additional loan amount borrowed								$ 2,500,000
Minimum excess availability on Combined Loan Cap		10.00%
Minimum amount excess availability on Combined Loan Cap		$ 7,000,000
Credit Facility Description of Variable Rate Basis						The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%.
Debt Instrument, frequency of periodic payment						Quarterly
Debt instrument, payment terms						The Term Loan can be prepaid at the Company's option subject to certain restrictions and subject to a prepayment premium as follows: 1) if the prepayment occurs on or prior to the second anniversary of the Closing Date, the greater of??a) interest on the prepayment that would otherwise have been paid with the 24 month period following the Closing Date minus actual interest payments made through the prepayment date and b) 2% of the prepayment and 2) 2% of the prepayment amount if paid between the second and third anniversary of the Closing Date.
Debt Instrument, frequency of periodic payment, commencing date						Jul. 31, 2018
Dividends payment or share repurchases prohibition period						3 years
Deferred financing costs						$ 2,460,000
Principal outstanding						$ 24,375,000
Proceeds from equipment financing transaction			$ 3,401,000
Term Loan | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Applicable margin rate		9.00%
Term Loan | Minimum
Debt Instrument [Line Items]
Debt instruments, periodic payments, principal		$ 312,500
Term Loan | Maximum
Debt Instrument [Line Items]
Loan available for borrowing		25,000,000
Prior Term Loan Agreement
Debt Instrument [Line Items]
Line of credit maturity date				Mar. 25, 2021
Repayment of existing balance		22,999,000
Payments of Financing Costs		3,226,000
Minimum excess availability on Combined Loan Cap									10.00%
Minimum amount excess availability on Combined Loan Cap									$ 10,000,000
Credit Facility Description of Variable Rate Basis						The interest rate on the Prior Term Loan was equal to a LIBOR rate (with a 1.0% LIBOR floor) plus 7.5%.
Long-term debt				$ 32,000,000
Additional reserve against availability under credit facility that will be reduced for prepayment of term loan									$ 5,000,000
Deferred financing costs		4,557,000
Loss on extinguishment of debt		$ (1,542,000)
Principal outstanding							$ 24,599,000
Prior Term Loan Agreement | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Applicable margin rate				7.50%
Debt instrument, interest rate				1.00%
Prior Term Loan Agreement | Minimum
Debt Instrument [Line Items]
Debt instruments, periodic payments, principal				$ 800,000

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018	Oct. 28, 2017
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Cash equivalents held by the Company	$ 4	$ 4
Outstanding borrowings under Credit Facility	$ 21,700	$ 8,000	$ 8,200
Term Loan | Minimum
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Annual variable interest rate	9.00%

Net Sales - Schedule of Disaggr

Net Sales - Schedule of Disaggregation of Company's Net Sales by Major Source (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Disaggregation of Revenue [Line Items]
Total net sales	$ 92,837	$ 96,354	$ 292,459	$ 301,060
Retail Stores [Member]
Disaggregation of Revenue [Line Items]
Total net sales	55,979	59,325	177,608	191,664
Leased Departments [Member]
Disaggregation of Revenue [Line Items]
Total net sales	9,743	10,292	29,624	32,752
Total Retail Locations [Member]
Disaggregation of Revenue [Line Items]
Total net sales	65,722	69,617	207,232	224,416
Ecommerce [Member]
Disaggregation of Revenue [Line Items]
Total net sales	21,045	20,539	69,530	57,615
Marketing Partnerships [Member]
Disaggregation of Revenue [Line Items]
Total net sales	4,110	4,475	12,236	13,004
Wholesale and Franchisee [Member]
Disaggregation of Revenue [Line Items]
Total net sales	$ 1,960	$ 1,723	$ 3,461	$ 6,025

Other Charges, Net - Additional

Other Charges, Net - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Other Charges Net Related To Proxy Solicitation And Proposed Merger And Management And Organizational Changes [Line Items]
Charges related to proxy solicitation	$ 83		$ 2,224
Charges related to Merger		$ 464		$ 1,113
Charges related to management and organizational changes	$ 1,742	$ 2,636	$ 2,674	$ 2,633
Orchestra-Premaman S.A., and Certain Other Affiliates of Orchestra
Other Charges Net Related To Proxy Solicitation And Proposed Merger And Management And Organizational Changes [Line Items]
Termination agreement entry date			Jul. 27, 2017

Other Charges, Net - Summary of

Other Charges, Net - Summary of Net Charges Incurred in Proxy Solicitation and Proposed Merger and Management and Organizational Changes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Proxy Solicitation and Proposed Merger
Proxy solicitation	$ 83		$ 2,224
Proposed merger		$ 464		$ 1,113
Total proxy solicitation and proposed merger	83	464	2,224	1,113
Management and Organizational Changes
Severance and related benefits	1,252	2,139	2,136	2,136
Consulting fees	490	497	538	497
Total management and organizational changes	1,742	2,636	2,674	2,633
Total other charges, net	$ 1,825	$ 3,100	$ 4,898	$ 3,746

Government Incentives - Additio

Government Incentives - Additional Information (Details) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Apr. 29, 2017USD ($)	Nov. 03, 2018USD ($)	Oct. 28, 2017USD ($)	Nov. 03, 2018USD ($)Job	Oct. 28, 2017USD ($)	Jan. 28, 2017USD ($)	Feb. 03, 2018USD ($)
Government Incentive Assistance Program [Line Items]
Deferred tax assets		$ 4,805		$ 4,805			$ 2,829
Grow New Jersey Assistance Program (Grow NJ)
Government Incentive Assistance Program [Line Items]
Income tax credits granted from state incentive package		40,000		$ 40,000
Transferrable income tax credit period				10 years
Government incentive assistance program award period				10 years
Project development, eligible amount per new full time job				$ 7
Government incentive assistance program annual award limit				$ 4,000
Award compliance period				5 years
Award Compliance Description				After the end of the ten-year Grow NJ award earnings period there is a five-year compliance period during which the Company must maintain the average of its annual eligible jobs certified during the preceding ten years or a pro-rata amount up to one-tenth of the previously awarded income tax credits would be subject to recapture and repayment to the State of New Jersey annually during the five-year compliance period.
Agreement to sell annual income tax credits awarded, Description				75% or more
Deferred tax assets		4,805		$ 4,805			$ 2,829
Cash proceeds net of costs from government incentive assistance program	$ 3,251
Income tax credits earned from state incentive package						$ 3,612
Cost reduction related to award		$ 617	$ 718	$ 1,902	$ 2,155
Grow New Jersey Assistance Program (Grow NJ) | Minimum
Government Incentive Assistance Program [Line Items]
Government incentive assistance program number of eligible jobs | Job				100

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details)	9 Months Ended	11 Months Ended	12 Months Ended
	Nov. 03, 2018	Dec. 31, 2017	Feb. 03, 2018
Income Tax Disclosure [Abstract]
Corporate tax rate	21.00%	35.00%	33.70%

Equity Award Plans - Additional

Equity Award Plans - Additional Information (Details) - shares	9 Months Ended	12 Months Ended
	Nov. 03, 2018	Feb. 03, 2018
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of stock options granted with exercise price less than fair market value on grant date	0	0
Non-employee director
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	1 year
Restricted stock, shares vested	4,000
2005 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options to be issued	3,550,000
Common stock shares issued, restricted stock units or deferred stock units	2,250,000
Common stock available for grant	896,848
Target cumulative performance-based restricted stock units available for future declaration	75,471
Maximum cumulative restricted stock units available for future declaration	150,942
2005 Plan | Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	4 years
Share-based payment award, expiration period	10 years
2005 Plan | Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	1 year
Awards that may be issued	177,500
2005 Plan | Performance-Based Awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Performance period	3 years
2005 Plan | Maximum | Restricted Stock and Time-Based RSU
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, expiration period	4 years
2005 Plan | Minimum | Restricted Stock and Time-Based RSU
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, expiration period	1 year
Non-executive chairman
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	1 year
Restricted stock, shares vested	6,000

Equity Award Plans - Stock Opti

Equity Award Plans - Stock Option Activity for All Plans (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Nov. 03, 2018USD ($)$ / sharesshares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Outstanding Stock Options, Beginning balance | shares	544
Outstanding Stock Options, Granted | shares	464
Outstanding Stock Options, Forfeited | shares	(483)
Outstanding Stock Options, Ending balance | shares	525
Outstanding Stock Options, Exercisable | shares	179
Weighted Average Exercise Price, Beginning balance | $ / shares	$ 11.26
Weighted Average Exercise Price, Granted | $ / shares	3.06
Weighted Average Exercise Price, Forfeited | $ / shares	8.44
Weighted Average Exercise Price, Ending balance | $ / shares	6.62
Weighted Average Exercise Price, Exercisable | $ / shares	$ 11.35
Weighted Average Remaining Life, Outstanding	8 years 4 months 24 days
Weighted Average Remaining Life, Exercisable	6 years 7 months 6 days
Aggregate Intrinsic Value, Ending balance | $	$ 598

Equity Award Plans - Summarizes

Equity Award Plans - Summarizes Information about Stock Options Outstanding (Details) shares in Thousands	9 Months Ended
	Nov. 03, 2018$ / sharesshares
2.65 to $ 5.00
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	$ 2.65
Range of Exercise Prices, upper range	$ 5
Stock Options Outstanding, Number Outstanding | shares	224
Stock Options Outstanding, Weighted Average Remaining Life	9 years 6 months
Stock Options Outstanding, Weighted Average Exercise Price	$ 2.65
5.01 to 10.00
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	5.01
Range of Exercise Prices, upper range	$ 10
Stock Options Outstanding, Number Outstanding | shares	199
Stock Options Outstanding, Weighted Average Remaining Life	8 years 4 months 24 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 6.36
Stock Options Exercisable, Number Exercisable | shares	91
Stock Options Exercisable, Weighted Average Exercise Price	$ 6.74
10.01 to 31.38
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	10.01
Range of Exercise Prices, upper range	$ 31.38
Stock Options Outstanding, Number Outstanding | shares	102
Stock Options Outstanding, Weighted Average Remaining Life	5 years 9 months 18 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 15.82
Stock Options Exercisable, Number Exercisable | shares	88
Stock Options Exercisable, Weighted Average Exercise Price	$ 16.16
2.65 to $31.38
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	2.65
Range of Exercise Prices, upper range	$ 31.38
Stock Options Outstanding, Number Outstanding | shares	525
Stock Options Outstanding, Weighted Average Remaining Life	8 years 4 months 24 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 6.62
Stock Options Exercisable, Number Exercisable | shares	179
Stock Options Exercisable, Weighted Average Exercise Price	$ 11.35

Equity Award Plans - Restricted

Equity Award Plans - Restricted Stock Activity (Details) shares in Thousands	9 Months Ended
	Nov. 03, 2018$ / sharesshares
Restricted stock activity for the 2005 Plan
Outstanding Restricted Shares, Unvested, beginning balance | shares	853
Outstanding Restricted Shares, Granted | shares	545
Outstanding Restricted Shares, Vested | shares	(144)
Outstanding Restricted Shares, Forfeited | shares	(649)
Outstanding Restricted Shares, Unvested, ending balance | shares	605
Weighted Average Grant Date Fair Value, Unvested, beginning balance | $ / shares	$ 3.16
Weighted Average Grant Date Fair Value, Granted | $ / shares	3.38
Weighted Average Grant Date Fair Value, Vested | $ / shares	3.81
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	2.89
Weighted Average Grant Date Fair Value, Unvested, ending balance | $ / shares	$ 3.49

Recent Accounting Pronounceme_4

Recent Accounting Pronouncements and Change in Accounting Principle - Impact of Adoption on Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Nov. 03, 2018	Feb. 03, 2018
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Inventories	$ 79,054	$ 71,256
Prepaid expenses and other current assets	10,270	$ 11,522
ASU 2014-09 | ASU 2014-09 Effect
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Inventories	(1,070)
Prepaid expenses and other current assets	1,070
ASU 2014-09 | Excluding ASU 2014-09 Effect
Revenue Initial Application Period Cumulative Effect Transition [Line Items]
Inventories	77,984
Prepaid expenses and other current assets	$ 11,340

Segment and Enterprise Wide D_3

Segment and Enterprise Wide Disclosures - Additional Information (Details)	9 Months Ended
	Nov. 03, 2018SegmentCustomer
Disclosure Segment And Enterprise Wide Disclosures Additional Information Detail [Abstract]
Number of operating segment | Segment	1
Number of customer who represented more than 10% of net sales | Customer	0

Segment and Enterprise Wide D_4

Segment and Enterprise Wide Disclosures - Operations by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017	Feb. 03, 2018
Net Sales
Net sales	$ 92,837	$ 96,354	$ 292,459	$ 301,060
United States
Net Sales
Net sales	88,006	90,584	278,057	283,676
Long-Lived Assets
Long-Lived Assets	54,696		54,696		$ 65,456
Foreign
Net Sales
Net sales	4,831	$ 5,770	14,402	$ 17,384
Long-Lived Assets
Long-Lived Assets	$ 1,325		$ 1,325		$ 1,643

Interest Expense, Net - Interes

Interest Expense, Net - Interest Expense, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Nov. 03, 2018	Oct. 28, 2017	Nov. 03, 2018	Oct. 28, 2017
Interest expense, net
Interest expense	$ 1,233	$ 1,006	$ 3,535	$ 2,991
Interest income	(1)		(2)	(2)
Interest expense, net	$ 1,232	$ 1,006	$ 3,533	$ 2,989